The Technical Analyst
Select Language :
Afya Ltd [AFYA]

Exchange: NASDAQ Sector: Consumer Defensive Industry: Education & Training Services

Afya Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Afya Ltd is listed at the  Exchange

-0.92% BRL16.13

America/New_York / 23 apr 2024 @ 13:58


FUNDAMENTALS
MarketCap: 1 511.75 mill
EPS: 0.810
P/E: 19.91
Earnings Date: May 13, 2024
SharesOutstanding: 93.72 mill
Avg Daily Volume: 0.122 mill
RATING 2024-04-23
A+
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Buy
DE: Buy
P/E: Buy
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
2.03x
Company: PE 19.91 | sector: PE 9.79
PE RATIO: COMPANY / INDUSTRY
0.89x
Company: PE 19.91 | industry: PE 22.48
DISCOUNTED CASH FLOW VALUE
BRL27.19
(68.59%) BRL11.06
Date: 2024-04-23
Expected Trading Range (DAY)

BRL 15.47 - 16.73

( +/- 3.93%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 14:07 - BRL16.10
Forecast 2: 14:57 - BRL16.10
Forecast 3: 15:37 - BRL16.10
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price BRL16.13 (-0.92% )
Volume 0.0255 mill
Avg. Vol. 0.122 mill
% of Avg. Vol 20.98 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Afya Ltd

Last 12 Months

Last 12 months chart data with high, low, open and close for Afya Ltd

RSI

Intraday RSI14 chart for Afya Ltd

Last 10 Buy & Sell Signals For AFYA

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:31buyBRL20.49N/AActive
Profile picture for
            Afya Ltd

AFYA

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

Last 10 Buy Signals

Date Signal @
KP3RUSDApr 23 - 13:5487.04
DPXUSDApr 23 - 13:5433.45
IEFApr 23 - 13:46$91.93
LNTApr 23 - 13:46$50.14
JBLUApr 23 - 13:43$6.24
ZIONApr 23 - 13:42$41.92
BZApr 23 - 13:42$18.77
AGNCApr 23 - 13:40$9.34
MNTUSDApr 23 - 13:391.180
AKTUSDApr 23 - 13:39$5.18

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.